Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status

被引:159
作者
Coscia, F. [1 ]
Watters, K. M. [2 ]
Curtis, M. [2 ]
Eckert, M. A. [2 ]
Chiang, C. Y. [2 ]
Tyanova, S. [1 ]
Montag, A. [3 ]
Lastra, R. R. [3 ]
Lengyel, E. [2 ]
Mann, M. [1 ]
机构
[1] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany
[2] Univ Chicago, Gynecol Oncol Sect, Dept Obstet & Gynecol, Chicago, IL 60637 USA
[3] Univ Chicago Med, Dept Pathol, Chicago, IL 60637 USA
关键词
FALLOPIAN-TUBE; RETINOIC ACID; MOLECULAR MARKER; EXPRESSION; IDENTIFICATION; GROWTH; QUANTIFICATION; METASTASIS; CRYSTALLIN; CARCINOMA;
D O I
10.1038/ncomms12645
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A cell line representative of human high-grade serous ovarian cancer (HGSOC) should not only resemble its tumour of origin at the molecular level, but also demonstrate functional utility in pre-clinical investigations. Here, we report the integrated proteomic analysis of 26 ovarian cancer cell lines, HGSOC tumours, immortalized ovarian surface epithelial cells and fallopian tube epithelial cells via a single-run mass spectrometric workflow. The in-depth quantification of 410,000 proteins results in three distinct cell line categories: epithelial (group I), clear cell (group II) and mesenchymal (group III). We identify a 67-protein cell line signature, which separates our entire proteomic data set, as well as a confirmatory publicly available CPTAC/TCGA tumour proteome data set, into a predominantly epithelial and mesenchymal HGSOC tumour cluster. This proteomics-based epithelial/mesenchymal stratification of cell lines and human tumours indicates a possible origin of HGSOC either from the fallopian tube or from the ovarian surface epithelium.
引用
收藏
页数:14
相关论文
共 69 条
[1]  
Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]
[2]  
[Anonymous], 2011, R: A Language and Environment for Statistical Computing
[3]  
[Anonymous], 2011, ACM T INTEL SYST TEC, DOI DOI 10.1145/1961189.1961199
[4]   The origin of ovarian carcinomas: A developmental view [J].
Auersperg, Nelly ;
Woo, Michelle M. M. ;
Gilks, C. Blake .
GYNECOLOGIC ONCOLOGY, 2008, 110 (03) :452-454
[5]  
Auersperg Nelly, 2013, Front Biosci (Schol Ed), V5, P709
[6]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[7]   Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes [J].
Beaufort, Corine M. ;
Helmijr, Jean C. A. ;
Piskorz, Anna M. ;
Hoogstraat, Marlous ;
Ruigrok-Ritstier, Kirsten ;
Besselink, Nicolle ;
Murtaza, Muhammed ;
van IJcken, Wilfred F. J. ;
Heine, Anouk A. J. ;
Smid, Marcel ;
Koudijs, Marco J. ;
Brenton, James D. ;
Berns, Els M. J. J. ;
Helleman, Jozien .
PLOS ONE, 2014, 9 (09)
[8]   The quantitative proteome of a human cell line [J].
Beck, Martin ;
Schmidt, Alexander ;
Malmstroem, Johan ;
Claassen, Manfred ;
Ori, Alessandro ;
Szymborska, Anna ;
Herzog, Franz ;
Rinner, Oliver ;
Ellenberg, Jan ;
Aebersold, Ruedi .
MOLECULAR SYSTEMS BIOLOGY, 2011, 7
[9]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[10]   Emerging roles for PAX8 in ovarian cancer and endosalpingeal development [J].
Bowen, Nathan J. ;
Logani, Sanjay ;
Dickerson, Erin B. ;
Kapa, Laura B. ;
Akhtar, Mariam ;
Benigno, Benedict B. ;
McDonald, John F. .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :331-337